EntyvioConnect Co-Pay Assistance Program
Takeda Pharmaceuticals U.S.A., Inc. · Entyvio
Patient pays: as little as $0 per dose (IV or Pen)
commercial insurance
How to apply: online or phone
Every Entyvio assistance program you may qualify for - manufacturer and foundation programs, not a discount card. About a minute, no login.
Every Entyvio program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Tell us five things. We’ll do the rest.
Entyvio (vedolizumab) is an anti-integrin biologic (alpha4beta7) made by Takeda Pharmaceuticals. It is commonly prescribed for: Ulcerative colitis (moderate-to-severe), Crohn's disease (moderate-to-severe).
Income limits
1 of the 2 active Entyvio assistance programs we track caps household income. The lowest cutoff is $79,800 a year for a single person. Most programs publish their cutoff as a percent of the federal poverty level - here is what that means in dollars.
Household income at or below 500% of the federal poverty level:
| Household size | Annual income limit |
|---|---|
| 1 person | $79,800 |
| 2 people | $108,200 |
| 3 people | $136,600 |
| 4 people | $165,000 |
| Each additional person | + $28,400 |
Dollar amounts for percent-of-poverty caps are computed from the 2026 federal poverty guidelines for the 48 contiguous states and Washington, DC ($15,960 for one person, plus $5,680 for each additional household member). Alaska and Hawaii use higher figures. Each program makes the final eligibility decision - confirm on the official application linked above.
Entyvio offers more than one kind of program, and they have opposite rules:
We show both programs, and the real income limits, below. Or read the full copay card vs patient assistance guide
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Takeda Pharmaceuticals U.S.A., Inc. · Entyvio
Patient pays: as little as $0 per dose (IV or Pen)
commercial insurance
How to apply: online or phone
Takeda Pharmaceuticals U.S.A., Inc. · Entyvio
uninsured · underinsured
How to apply: online, phone, mail, or fax
Your prescriber signs part of the form.
Yes. Takeda Pharmaceuticals U.S.A., Inc. runs the ENTYVIO Patient Assistance Program (Takeda Help at Hand), which provides Entyvio free of charge to eligible patients. Household income generally needs to be at or below 500% of the federal poverty level. The full rules and the official application link are in the program list above.
Medicare coverage for Entyvio depends on your own plan: depending on how it is given, a drug can fall under Part B (administered in a clinic) or Part D (filled at a pharmacy), and each plan decides what it covers. Your plan's documents or Medicare's plan finder are the only reliable check. Separate from coverage, none of the Entyvio assistance programs we track currently accept Medicare patients.
Yes - the EntyvioConnect Co-Pay Assistance Program from Takeda Pharmaceuticals U.S.A., Inc. Eligible patients pay as little as $0 per dose (IV or Pen). It works for patients with commercial (private) insurance. Patients on Medicare or Medicaid cannot use the card itself. If you searched for an Entyvio coupon, this manufacturer card is the official version of it.
The official application form for the ENTYVIO Patient Assistance Program (Takeda Help at Hand) is on helpathandpap.com - the application links on this page go straight to the program's own form. Some programs call it an enrollment form; it is the same document. Applying is always free; never pay a third-party service to file a patient assistance form for you.
None of the Entyvio programs we track currently accept Medicare or Medicaid. If that changes, we will update this page.
Manufacturers like Takeda Pharmaceuticals use "patient support program" as an umbrella term for nurse lines, insurance navigation, and financial help. The financial help is what we track here - for Entyvio that is the ENTYVIO Patient Assistance Program (Takeda Help at Hand). The support phone line is listed on the official program site linked above.